Knockdown (KD) of KAT6A with two different shRNAs significantly decreased cell proliferation (Figure 1H; Figure S1B, Supporting Information) in MDA‐MB‐231 and BT‐549 cells and orthotopic xenograft tumor growth (Figure S1C,D, Supporting Information). Here, KAT6A is linked to neoplasm.